• Approach

    Learn about our collaborative models

  • Focus

    Read about our core research themes

  • Collaboration

    Learn about our key partnerships

First Dementia Consortium Project Launched

Brain inflammation targeted in first drug discovery project from £3m Dementia Consortium

Funding worth nearly half a million pounds will unite academics at the University of Southampton with drug discovery experts at the medical research charity MRC Technology, to target the immune system in the hunt for new treatments for Alzheimer’s disease. 

Dementia Consortium Logo 306Px

The work is the first to be funded by the Dementia Consortium – a unique £3m drug discovery collaboration between Alzheimer’s Research UK, MRC Technology and the pharmaceutical companies Eisai and Lilly. By uniting expertise, this focused cash injection will bridge the gap between academic research and the pharmaceutical industry in the search for new drugs to slow the development of Alzheimer’s.

To read the full press release click here

InflamationNeurodegenerationGeneral MedcineGenomics